prof. dr. Ben Vanneste

Rare type of Bellini duct carcinoma in a patient with Cacchi–Ricci disease : a case report and mini-review

Antonio Franco, Thomas Tailly (UGent) , Camille Berquin (UGent) , Daan De Maeseneer (UGent) , Alexander Decruyenaere (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , Kathia De Man (UGent) , Laurens Hermie (UGent) , Ben Vanneste (UGent) , et al.

(2024) CLINICAL GENITOURINARY CANCER. 22(6).

Add to list

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Flor Verghote (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Ben Vanneste (UGent) , Sara Junius, Nick Liefhooghe, Leen Noé, Gert De Meerleer, Piet Ost (UGent) , et al.

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 194(Supplement 1). p.S2308-S2311

Add to list

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Valerie Fonteyne (UGent) , C Berghen, Charles Van Praet (UGent) , Barbara Vanderstraeten (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Roos Colman (UGent) , Ben Vanneste (UGent) , Piet Ost (UGent) , G De Meerleer, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 193.

Add to list

Journal Article
A1
open access

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

Flor Verghote (UGent) , Charles Van Praet (UGent) , Camille Berquin (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Ben Vanneste (UGent) , Elke Rammant (UGent) and Valerie Fonteyne (UGent)

(2024) BMC CANCER. 24(1).

Add to list

Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?

Edward Lambert (UGent) , Charlotte Allaeys, Camille Berquin (UGent) , Pieter De Visschere (UGent) , Sofie Verbeke (UGent) , Ben Vanneste (UGent) , Valerie Fonteyne (UGent) , Charles Van Praet (UGent) and Nicolaas Lumen (UGent)

(2023) EAU23 - 38th Annual EAU Congress, Abstracts.

Add to list

Journal Article
A1
open access

Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?

Edward Lambert (UGent) , Charlotte Allaeys, Camille Berquin (UGent) , Pieter De Visschere (UGent) , Sofie Verbeke (UGent) , Ben Vanneste (UGent) , Valerie Fonteyne (UGent) , Charles Van Praet (UGent) and Nicolaas Lumen (UGent)

(2023) CURRENT ONCOLOGY. 30(3). p.3447-3460

Add to list

Journal Article
A4
open access

Indicaties voor radiotherapie bij blaaskanker met spierinvasie

Flor Verghote (UGent) , Charles Van Praet (UGent) , Daan De Maeseneer (UGent) , Camille Berquin (UGent) , Ben Vanneste (UGent) , Pieter De Visschere (UGent) , Sofie Verbeke (UGent) and Valerie Fonteyne (UGent)

(2023) ONCO (NEDERLANDSE ED.). 17(7). p.6-10

Add to list

Journal Article
A1
open access

Dosimetric and hematologic implications of prostate-only versus whole pelvic radiotherapy : results of the multicentric phase 3 PROPER study

Valerie Fonteyne (UGent) , Willeke Danckaert (UGent) , Piet Ost (UGent) , Charlien Berghen, Katrien Vandecasteele (UGent) , Ben Vanneste (UGent) , Kato Rans, Nick Liefhooghe, Steven Wallaert (UGent) and Leen Paelinck (UGent)

(2023) TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 22.

Add to list

Journal Article
A2
open access

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martínez-Calvo, Ceilidh Welsh, Tom Dudding, et al.

(2023) JNCI CANCER SPECTRUM. 7(6).

Add to list

Journal Article
A1
open access

Radiotherapy use in muscle-invasive bladder cancer : review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium

Flor Verghote (UGent) , Charles Van Praet (UGent) , Daan De Maeseneer (UGent) , Camille Berquin (UGent) , Ben Vanneste (UGent) , Pieter De Visschere (UGent) , Sofie Verbeke (UGent) and Valerie Fonteyne (UGent)

(2023) CANCER MANAGEMENT AND RESEARCH. 15. p.511-521

Academic Bibliography

prof. dr. Ben Vanneste

Rare type of Bellini duct carcinoma in a patient with Cacchi–Ricci disease : a case report and mini-review

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?

Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?

Indicaties voor radiotherapie bij blaaskanker met spierinvasie

Dosimetric and hematologic implications of prostate-only versus whole pelvic radiotherapy : results of the multicentric phase 3 PROPER study

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Radiotherapy use in muscle-invasive bladder cancer : review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium

Contents

Support

Contact